Generate Biomedicines, Inc.
15.52USD
-0.3800 (-2.39%)
Fetching financial statements from SEC filings…
| In $M except per-share | Q2 FY26 | Q1 FY26 | Q2 FY25 | Q1 FY25 |
|---|---|---|---|---|
| Revenue | 6 | 7 | 10 | 9 |
| Cost of Revenue | — | — | — | — |
| Gross Profit | — | — | — | — |
| Operating Income | -72 | -64 | -60 | -48 |
| Net Income | -67 | -61 | -52 | -42 |
| EPS (Diluted) | $-0.52 | $-1.07 | $-1.94 | $-1.62 |
Source: SEC filings (EDGAR)